Christian K. Schneider, MD National Institute for Biological Standards and Control

Christian K. Schneider, M.D., is Director of the National Institute for Biological Standards and Control (NIBSC), UK, a centre of the Medicines and Healthcare products Regulatory Agency (MHRA). Previous positions include Medical Head of Division Medicines Licensing and Availability at the Danish Medicines Agency, and Head of Division "EU Co-operation/Microbiology" at the Paul-Ehrlich-Institute, the German Federal Agency for Vaccines and Biomedicines. Previous Roles at the European Medicines Agency include Chair of the Biosimilar Medicinal Products Working Party (BMWP; 2007-2016), Chair of the Committee for Advanced Therapies (CAT; 2009-2013), and co-opted member of the Committee for Medicinal Products for Human Use (CHMP; 2007-2011, co-opted for the area of "Quality and safety (biological), with expertise in Advanced Therapies - Gene, Cell and Tissue Therapies"). Christian K. Schneider was working for more than two years as a postdoctoral researcher at the Max-Planck-Institute for Neurobiology, Neuroimmunology (Martinsried, Germany), where he worked in experimental immunology in the field of T cell immunology of inflammatory myopathies and multiple sclerosis. During his clinical career, Christian K. Schneider worked in clinical immunology and hemato-oncology (Department of Internal Medicine III, University Erlangen-Nuremberg, Germany).